• Arnarsson A, Jonasson F, Sasaki H, Ono M, Jonsson V, Kojima M, Katoh N & Sasaki K (2002): Risk factors for nuclear lens opacification: the Reykjavik Eye Study. Dev Ophthalmol 35: 1220.
  • Chylack LT Jr, Leske MC, McCarthy D, Khu P, Kashiwagi T & Sperduto R (1989): Lens opacities classification system II (LOCS II). Arch Ophthalmol 107: 991997.
  • Foster PJ, Wong TY, Machin D, Johnson GJ & Seah SK (2003): Risk factors for nuclear, cortical and posterior subcapsular cataracts in the Chinese population of Singapore: the Tanjong Pagar Survey. Br J Ophthalmol 87: 11121120.
  • Hennis A, Wu SY, Nemesure B & Leske MC (2004): Risk factors for incident cortical and posterior subcapsular lens opacities in the Barbados Eye Studies. Arch Ophthalmol 122: 525530.
  • Jansson SP, Andersson DK & Svardsudd K (2007): Prevalence and incidence rate of diabetes mellitus in a Swedish community during 30 years of follow-up. Diabetologia 50: 703710.
  • Katoh N, Jonasson F, Sasaki H, Kojima M, Ono M, Takahashi N & Sasaki K (2001): Cortical lens opacification in Iceland. Risk factor analysis – Reykjavik Eye Study. Acta Ophthalmol Scand 79: 154159.
  • Klein BE, Klein R & Moss SE (1985): Prevalence of cataracts in a population-based study of persons with diabetes mellitus. Ophthalmology 92: 11911196.
  • Klein BE, Klein R & Moss SE (1995a): Incidence of cataract surgery in the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Am J Ophthalmol 119: 295300.
  • Klein BE, Klein R, Wang Q & Moss SE (1995b): Older-onset diabetes and lens opacities. The Beaver Dam Eye Study. Ophthalmic Epidemiol 2: 4955.
  • Klein BE, Klein R & Lee KE (1998): Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: the Beaver Dam Eye Study. Am J Ophthalmol 126: 782790.
  • Leske MC, Wu SY, Nemesure B & Hennis A (2002): Risk factors for incident nuclear opacities. Ophthalmology 109: 13031308.
  • Pollreisz A & Schmidt-Erfurth U (2010): Diabetic cataract-pathogenesis, epidemiology and treatment. J Ophthalmol 2010: 608751.
  • Rowe NG, Mitchell PG, Cumming RG & Wans JJ (2000): Diabetes, fasting blood glucose and age-related cataract: the Blue Mountains Eye Study. Ophthalmic Epidemiol 7: 103114.
  • Sasaki H, Jonasson F, Kojima M, Katoh N, Ono M, Takahashi N & Sasaki K (2000): The Reykjavik Eye Study – prevalence of lens opacification with reference to identical Japanese studies. Ophthalmologica 214: 412420.
  • Saxena S, Mitchell P & Rochtchina E (2004): Five-year incidence of cataract in older persons with diabetes and pre-diabetes. Ophthalmic Epidemiol 11: 271277.
  • Schmier JK, Halpern MT, Covert DW & Matthews GP (2007): Evaluation of costs for cystoid macular edema among patients after cataract surgery. Retina 27: 621628.
  • Stanga PE, Boyd SR & Hamilton AM (1999): Ocular manifestations of diabetes mellitus. Curr Opin Ophthalmol 10: 483489.
  • Tranos PG, Wickremasinghe SS, Stangos NT, Topouzis F, Tsinopoulos I & Pavesio CE (2004): Macular edema. Surv Ophthalmol 49: 470490.
  • Varma R & Torres M (2004): Prevalence of lens opacities in Latinos: the Los Angeles Latino Eye Study. Ophthalmology 111: 14491456.
  • WHO Study Group (1985): Diabetes mellitus: technical report series 727. Geneva: World Health Organization.
  • Zaczek A, Olivestedt G & Zetterstrom C (1999): Visual outcome after phacoemulsification and IOL implantation in diabetic patients. Br J Ophthalmol 83: 10361041.